Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01241747 · ClinicalTrials.gov registry record · NA

Exercise for Women With Peripheral Arterial Disease

A NA study of Peripheral Artery Disease and Women, sponsored by University of Oklahoma.

Completed
Registry status
NA
Development phase
33
Enrollment target
1
Study location

NCT01241747 is a NA study of Peripheral Artery Disease and Women that has completed, run by University of Oklahoma. The registered enrollment target is 33 participants, below the 126-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01241747, a NA study of Peripheral Artery Disease and Women, has completed, sponsored by University of Oklahoma.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target
1
Study location

Study Summary

Hypothesis #1. Supervised exercise rehabilitation will result in greater increases in exercise performance, peripheral vascular function, and health-related quality of life than compared to the attention-control group. Hypothesis #2. The change in peripheral vascular function will be predictive of improved exercise performance following the supervised exercise program.

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Walking Exercise

Study Locations (1)

Pennsylvania

  • Clinical Research Center, Penn State College of Medicine - Hershey

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2009-07
Est. Completion 2016-02
Phase NA

Sponsor

University of Oklahoma

358 total trials

What the Registry Record Tells You About NCT01241747

The ClinicalTrials.gov registry entry for NCT01241747 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 126-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (74% lower). The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Peripheral Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.

NCT01241747 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01241747 about?

NCT01241747 is a clinical study titled "Exercise for Women With Peripheral Arterial Disease". Hypothesis #1. Supervised exercise rehabilitation will result in greater increases in exercise performance, peripheral vascular function, and health-related quality of life than compared to the attention-control group. Hypothesis #2. The change in peripheral vascular function will be predictive of ...

What is the current status of trial NCT01241747?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2009-07. Estimated completion is 2016-02.

What conditions does trial NCT01241747 study?

This clinical trial studies the following conditions: Peripheral Artery Disease, Women, Claudication.

What interventions are being tested in trial NCT01241747?

The interventions under investigation include: Control (BEHAVIORAL), Walking Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT01241747?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01241747 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Peripheral Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.